MetaTrader
  • Mercati
  • Grafici & Idee
  • Algo
  • Notizie
  • Store
  • Broker
  • Scarica
  • Calendario Economico
  • Segnali di Trading
  • Terminale Web
  • English English
  • Русский Русский
  • 中文 中文
  • Español Español
  • Português Português
  • 日本語 日本語
  • Deutsch Deutsch
  • Français Français
  • Italiano Italiano
  • Türkçe Türkçe
Protagonist Therapeutics, Inc

PTGX

#1033
Protagonist Therapeutics, Inc
92.0800
+6.88%
Settore:
Base:
Valuta di Profitto:
Intervallo Giornaliero
92.0800
92.2200
Intervallo Annuale
74.0250
96.5400
Variazione giornaliera
+6.88%
Variazione Mensile
+11.68%
Variazione di 6 mesi
+22.56%
Variazione Annuale
+22.56%
Chiusura Precedente
86.1500
Open
92.2100
Bid
Ask
Low
92.0800
High
92.2200
Volume
152
  1. Mercati
  2. Mercato Azionario Statunitense
  3. Salute
  4. PTGX
Open full chart

Financials

Overview Estratto Conto Statistics Dividends
Quarterly Annual
Value Q3, 24Q4, 24Q1, 25Q2, 25Q3, 25Q4, 25 TTM

Notizie

Investing Investing
PTGX
2026.02.26
Protagonist Therapeutics Q4 실적, 수익 에상치보다 저조
Investing Investing
PTGX
2026.02.26
Protagonist Therapeutics earnings missed by $0.35, revenue fell short of estimates
Investing Investing
JNJ TAK PTGX
2026.02.26
시티즌스, Protagonist Therapeutics 목표 주가 상향
Investing Investing
PTGX
2026.02.26
Citizens raises Protagonist Therapeutics stock price target on drug approvals
Investing Investing
PTGX
2026.02.18
Protagonist Therapeutics 임원, 19억 원 상당 주식 매도
Investing Investing
PTGX
2026.02.18
Protagonist Therapeutics director Williams sells $1.48 million in shares
Investing Investing
PTGX
2026.02.07
프로타고니스트 테라퓨틱스 이사, 167만 달러 상당 주식 매도
Investing Investing
PTGX
2026.02.07
Protagonist Therapeutics director sells $1.67 million in shares
Investing Investing
CYTK MDGL PTGX SRRK TERN
2026.02.03
2026년 주목할 바이오테크 주요 종목: 트루이스트
Investing Investing
CYTK MDGL PTGX SRRK TERN
2026.02.03
Top Biotech Stocks to Watch in 2026, According to Truist
Investing Investing
PTGX
2026.01.30
Protagonist Therapeutics 목표 주가, H.C. Wainwright서 117달러로 상향
Investing Investing
PTGX
2026.01.30
Protagonist Therapeutics stock price target raised to $117 from $80 at H.C. Wainwright

Mercati

  • Mercato Azionario Americano
  • Valute
  • Criptovalute
  • Metalli
  • Materie Prime

Grafici & Idee

  • Idee di Trading
  • Idee Educative
  • Grafici

MQL5 Community

  • Market
  • Segnali
  • Forum
  • Articoli
  • CodeBase

Notizie

  • Mercato Azionario Americano
  • Valute
  • Criptovalute
  • Metalli
  • Materie Prime

Broker

  • Tutti i Broker
  • Forex
  • Azioni
  • Metalli
MetaTrader 5
MQL5 Channels
Economic Calendar
Esclusione di Responsabilità e Informativa sui Rischi Termini di Utilizzo Contatti e richieste Legale
Copyright 2000-2026, MetaQuotes Ltd